Intelicanna is a vertically integrated medical cannabis company based in Israel that is publicly traded on the Tel Aviv Stock Exchange. Intelicanna cultivates consistent, high quality medical cannabis for the local Israeli market in its state of the art, Snow-White Medifarm Cultivation Facility. The facility incorporates various agro and automation technologies that enhance the consistency and quality of our cannabis.
Internationally, Intelicanna is pursuing and evaluating multiple business development opportunities for expanding its operations into various international markets.
Founded in 2010, Mycolivia is a leading company in the field of research, development and distribution of medicinal mushroom based products. The company recently began combining the medicinal benefits of mushrooms and cannabis to create a line of IP protected, fixed-dose combination products that enhance the effectiveness of cannabis. The company is in the process of going public on the CSE.
The focus of Alvit’s initial product launch strategy is establishing a base of operations in the EU to pursue the nascent European market. To this end, Alvit has successfully completed negotiations with government representatives of Malta and has received an LOI for licenses to import, cultivate, research, manufacture, sell, and export cannabis products into the EU and other European markets. The construction of a GACP indoor eco-cultivation and EU-GMP production facility is under way with the anticipation of beginning to manufacture and market products in the EU during the first half of 2020.
Alvit will enter the European market by launching its flowers, oils and products into the German marketplace in the beginning of 2020.